| Name | Title | Contact Details |
|---|
We`re making healthcare transformation personal. Driving down the cost of chronic conditions is going to take all of us. Welldoc is here to help with BlueStar, our in-app digital assistant for type 2 diabetes. Chronic with ease. Working together to redefine how engaging and personally transformative technology can be will lead to real change: starting and evolving habits, taking daily responsibility for our well-being, and moving outcomes and costs to a much more manageable place. Technology and teamwork. It`s time to make every moment, every action, every healthcare decision count.
Prematics, Inc is a Mclean, VA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
Jackson Healthcare is built on a simple idea — that talented professionals with a shared purpose can improve the lives of patients, families and communities. Headquartered in Alpharetta, Georgia, the company has risen to a place of prominence among the largest healthcare staffing and technology companies in the U.S. It currently serves more than seven million patients in over 1,300 healthcare facilities. In addition to serving health systems and providers, Jackson champions local, national and international charitable work. It founded and sponsors the Hospital Charitable Service Awards, which honors programs that set new standards for health and wellness in their communities through education, access and delivery. Atlanta Business Chronicle named Jackson Healthcare the city’s “Best Place to Work” in 2014, 2015, and 2016 and “Healthiest Large Company” in 2015.
MolecularMD founders Brian Druker (lead clinical investigator for Gleevec, the first molecularly-targeted anticancer agent) and Sheridan G. Snyder (entrepreneur, founder of Genzyme and Upstate Biotechnology) came together with the mission of providing precise, standardized molecular testing for new oncology drugs. The company’s initial accomplishment was in developing and implementing the only standardized assay for quantification of BCR-ABL expression levels, which proved critical to pharmaceutical sponsors in satisfying regulators for approval of the second-generation ABL kinase inhibitors nilotinib (Tasigna, Novartis) and dasatinib (Sprycel, BMS). With that foundational success in supporting pivotal international studies with centralized, high-quality diagnostic services, MolecularMD has become a preferred provider of molecular diagnostics products and services to pharmaceutical and biotech drug developers. Capabilities range from specialty molecular testing services performed in MolecularMD’s centralized CLIA-certified and CAP-accredited laboratory, to development of FDA approved companion diagnostics to support new drug registrations.
Medfusion, a Cary, NC-based company offers patient-provider communication solutions nationally to enable healthcare providers offer superior service to their patients while improving office efficiency and generating revenue.